mRNA expression
Gene:
CTAG1B (official gene symbol)Other symbol:
CTAG1BCT family:
CT6CT identifier:
CT6.1Aliases from NCBI:
CTAG , CTAG1 , ESO1 , LAGE-2 , LAGE2B , NY-ESO-1Unified entry for genes CTAG1B, CTAG1A (nearly-identical copies)
Gene expression pattern ? : Testis-selective
High-throughput data (expression in cancer samples)
SAGE(short, 10 nt tags) Show
SAGE(long, 17 nt tags) Show
MPSS (short, 13 nt tags) Show
EST Show
Published data of mRNA expression in normal tissues
Show| Tissue | Methodology | PMID |
|---|---|---|
| Placenta | RT-PCR | 14738373 |
| Testis | RT-PCR | 14738373 |
| Pancreas | RT-PCR | 14738373 |
| Liver | RT-PCR | 14738373 |
| Testis | RT-PCR | 9050879 |
| Ovary | RT-PCR | 9050879 |
| Uterus | RT-PCR | 9050879 |
| Testis | qRT-PCR | 15475443 |
| Testis | qRT-PCR | 15586225 |
| Liver | qRT-PCR | 15586225 |
| Pancreas | qRT-PCR | 15586225 |
| Placenta | qRT-PCR | 15586225 |
| Testis | qRT-PCR | 15026363 |
| Bone marrow | Nested RT-PCR | 15781633 |
| Mesenchymal stem cells | Nested RT-PCR | 15781633 |
| Fetal mesenchymal stem cells | Nested RT-PCR | 15781633 |
| Testis | RT-PCR | 18237105 |
| Placenta | RT-PCR | 18237105 |
| Mammary gland | RT-PCR | 18237105 |
| Mesenchymal stem cells | RT-PCR | 21187485 |
Published data of mRNA expression in neoplasias
Hematologic malignacies Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Myeloma |
4/55 (7.3%) | RT-PCR | 17023585 | |
| Myeloma |
13/39 (36%) | RT-PCR | 18237105 | |
| Adult T-cell leukemia/lymphoma (ATLL) |
35/57 (61%) | RT-PCR | 22323448 |
Bladder cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Transitional cell carcinoma |
46/102 (45%) | RT-PCR | 21396841 | |
| Urothelial carcinoma |
122/350 (35%) | qRT-PCR | 22596240 |
Brain cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Glioma |
0/15 (0%) | RT-PCR | 9050879 | |
| Medulloblastoma (Pediatric) |
1/11 (9%) | qRT-PCR | 18398575 | |
| Glioma |
1/30 (3%) | RT-PCR | 18240144 | |
| Medulloblastomas |
5/25 (20%) | RT-PCR | 18426187 | |
| Glioma |
0/43 (0%) | RT-PCR | 22534618 | |
| Meningioma |
3/26 (12%) | RT-PCR |
Esophageal cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Squamous cell carcinoma |
17/41 (41%) | RT-PCR | 21613820 |
Head & Neck cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Oral squamous cell carcinoma |
18/65 (28%) | RT-PCR | 20044626 | |
| Squamous cell carcinoma |
Primary tumor | 3/57 (6%) | RT-PCR | 20715104 |
Hepatobiliary cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Hepatoma |
2/7 (29%) | RT-PCR | 9050879 | |
| Hepatocellular carcinoma |
4/36 (1.1%) | RT-PCR | 17637219 | |
| Hepatocellular carcinoma |
31/73 (42%) | RT-PCR | 15723723 | |
| Intraepithelial cholangiocarcinoma |
2/20 (10%) | RT-PCR | 15466353 | |
| Hepatocellular carcinoma |
0/21 (0%) | RT-PCR | 12747756 | |
| Hepatocellular carcinoma |
12/30 (40%) | RT-PCR | 12681059 | |
| Hepatocellular carcinoma |
18/41 (44%) | RT-PCR | 16872310 | |
| Hepatocellular carcinoma |
10/30 (33%) | RT-PCR | 16091172 | |
| Hepatocellular carcinoma |
17/62 (27%) | RT-PCR | 15890110 | |
| Hepatocellular carcinoma |
9/34 (27%) | RT-PCR | 15730810 | |
| Liver carcinoma |
10/38 (26.3%) | qRT-PCR | 15586225 | |
| Hepatocellular carcinoma |
12/49 (24%) | RT-PCR | 15240519 |
Lung cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Non small cell lung carcinoma |
Primary tumor | 1/42 (2%) | RT-PCR | 14512184 |
| Small cell lung carcinoma |
Primary tumor | 0/4 (0%) | RT-PCR | |
| Lung carcinoma |
2/12 (17%) | RT-PCR | 9050879 | |
| Adenocarcinoma |
5/37 (14%) | RT-PCR | 16353146 | |
| Adenosquamous carcinoma |
1/3 (33%) | RT-PCR | ||
| Large cell carcinoma |
2/9 (22%) | RT-PCR | ||
| Squamous cell carcinoma |
11/41 (27%) | RT-PCR | ||
| Undifferentiated lung carcinoma |
4/12 (33%) | RT-PCR | ||
| Non small cell lung carcinoma |
7/33 (21%) | RT-PCR | 10704737 | |
| Non small cell lung carcinoma |
139/523 (27%) | RT-PCR | 16299236 | |
| Adenocarcinoma |
3/25 (12%) | qRT-PCR | 16468707 | |
| Adenocarcinoma |
2/53 (3.8%) | RT-PCR | 16596224 | |
| Large cell carcinoma |
0/9 (0%) | RT-PCR | ||
| Squamous cell carcinoma |
8/41 (19%) | RT-PCR | ||
| Lung carcinoma |
3/50 (6%) | qRT-PCR | 15586225 | |
| Non small cell lung carcinoma |
Primary tumor | 20/63 (32%) | RT-PCR | 15069548 |
| Non small cell lung carcinoma |
25/239 (10%) | RT-PCR | 19545928 |
Melanocytic lesion Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Melanoma |
23/67 (34%) | RT-PCR | 9050879 | |
| Melanoma |
Primary tumor | 0/20 (0%) | RT-PCR | 11397121 |
| Melanoma |
Distant metastasis | 4/10 (40%) | RT-PCR | |
| Melanoma |
Locoregional metastasis | 7/22 (32%) | RT-PCR | |
| Melanoma |
50/120 (42%) | qRT-PCR | 15623618 | |
| Melanoma |
2/20 (10%) | qRT-PCR | 15586225 | |
| Melanoma |
Metastatic tumor | 14/63 (23%) | RT-PCR | 11120859 |
| Melanoma |
10/23 (44%) | RT-PCR | 9766577 | |
| Melanoma |
143/202 (71%) | RT-PCR | 19326132 |
Ovarian cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Ovarian carcinoma |
2/8 (25%) | RT-PCR | 9050879 | |
| Ovarian carcinoma |
2/20 (10%) | qRT-PCR | 15586225 | |
| Ovarian carcinoma |
32/107 (30%) | RT-PCR | 14522938 |
Sarcoma Show
Published data of mRNA expression in Cell Lines
Show| Origin tissue | Cell Line ID | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Glioblastoma multiforme | U87MG SNB19 ONS-23 |
3/4 (75%) | RT-PCR | 20082319 |
| Melanoma | Me 275/CI2 Me312 Me325 Me333 Me343 Me342 Me257 Me242.B.1 Me252 SK-Mel-37 518/IL-2.14 FM6 |
12/35 (34%) | RT-PCR | 11120859 |
| Melanoma | WM115-A WM1972-A WM1976-A |
3/4 (75%) | RT-PCR | 18205182 |
| Melanoma stem cells (MSC) | WM115-NA WM1972-NA WM1976-NA WM3130-NA |
4/4 (100%) | RT-PCR | 18205182 |
| Myeloma | IM9 EJM U-266 Brown KMS-12-BM MOLP-8 NCI-H929 OPM-2 SK-007 |
9/11 (82%) | RT-PCR | 17023585 |
| Pancreatic adenocarcinoma | Patu | 1/10 (10%) | RT-PCR | 14991579 |
| Sarcoma | Saos-2 HT-1080 |
2/8 (25%) | RT-PCR | 15298487 |
2005-2009© CT Antigens Database